These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33178581)

  • 1. Ten-Year Outcomes of Percutaneous Radiofrequency Ablation for Colorectal Cancer Liver Metastases in Perivascular vs. Non-Perivascular Locations: A Propensity-Score Matched Study.
    Jiang B; Luo H; Yan K; Zhang Z; Li X; Wu W; Yang W; Chen M
    Front Oncol; 2020; 10():553556. PubMed ID: 33178581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
    Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
    Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival.
    Akhan O; Akçalar S; Ünal E; Metin Y; Çiftçi T; Akıncı D
    Turk J Gastroenterol; 2023 Jun; 34(6):645-651. PubMed ID: 37232461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.
    Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
    Radiology; 2014 Mar; 270(3):888-99. PubMed ID: 24475820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
    Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factors.
    Klubien J; Rosenberg J; Skjoldbye BO; Lorentzen T; Nolsøe CP; Pommergaard HL
    Ultrasonography; 2023 Jul; 42(3):410-420. PubMed ID: 37337360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ablation of colorectal liver metastases: a comparison between the outcomes of grayscale US guidance and Sonazoid CEUS Kupffer phase guidance using propensity score matching.
    Qin S; Zhou J; Cui R; Chen Y; Wang Y; Liu G
    Int J Hyperthermia; 2023; 40(1):2260573. PubMed ID: 37788806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
    Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
    Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural risk factors for incomplete radiofrequency ablation of liver metastases from colorectal cancer: a single-center retrospective analysis.
    Fan H; Wang X; Qu J; Lu W; Pang Z; Shao T; Xia J; Wang H; Li G; Zhang Y; Sun J; Yang X
    Int J Hyperthermia; 2021; 38(1):985-994. PubMed ID: 34167430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?
    Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J
    Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
    Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
    Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.
    Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT
    Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
    Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
    Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection--Propensity Score Analyses of Long-term Outcomes.
    Kang TW; Kim JM; Rhim H; Lee MW; Kim YS; Lim HK; Choi D; Song KD; Kwon CH; Joh JW; Paik SW; Paik YH; Ahn JH
    Radiology; 2015 Jun; 275(3):908-19. PubMed ID: 25688888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.